Repaglinide

Replaglinide is the active ingredient in an antidiabetic drug known commercially as Novonorm. This oral medicinal product is indicated for the treatment of diabetes in people who are not dependent on insulin. The action of repaglinide consists of the release of insulin by the cells of the pancreas, thus regulating the concentration of blood sugar. […]